2017
Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program
BARRET, J.P., F. PODMELLE, Břetislav LIPOVÝ, H.O. RENNEKAMPFF, H. SCHUMANN et. al.Základní údaje
Originální název
Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program
Autoři
BARRET, J.P., F. PODMELLE, Břetislav LIPOVÝ, H.O. RENNEKAMPFF, H. SCHUMANN, A. SCHWIEGER-BRIEL, T.R. ZAHN a H.R. METELMANN
Vydání
Burns, OXFORD, ELSEVIER SCI LTD, 2017, 0305-4179
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30218 General and internal medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.134
Organizační jednotka
Lékařská fakulta
UT WoS
000410623300019
Klíčová slova anglicky
Wound healing; Topical betulin gel; Split thickness skin graft; Intra-individual comparison; Wound closure
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2018 14:04, Soňa Böhmová
Anotace
V originále
The clinical significance of timely re-epithelialization is obvious in burn care, since delayedwound closure is enhancing the risk of wound site infection and extensive scarring. Topical treatments that accelerate wound healing are urgently needed to reduce these sequelae. Evidence from preliminary studies suggests that betulin can accelerate the healing of different types of wounds, including second degree burns and split-thickness skin graft wounds. The goal of this combined study program consisting of two randomized phase III clinical trials in parallel is to evaluate whether a topical betulin gel (TBG) is accelerating reepithelialization of split-thickness skin graft (STSG) donor site wounds compared to standard of care. Two parallel blindly evaluated, randomised, controlled, multicentre phase III clinical trialswere performed in adults undergoing STSG surgery (EudraCT nos. 2012-003390-26 and 2012-000777-23). Donor site wounds were split into two equal halves and randomized 1: 1 to standard of care (a non-adhesive moist wound dressing) or standard of care plus TBG consisting of 10% birch bark extract and 90% sunflower oil (Episalvan, Birken AG, Nieferm-Oeschelbronn, Germany). The primary efficacy assessment was the intra-individual difference in time to wound closure assessed from digital photographs by three blinded experts. A total of 219 patients were included and treated in the two trials. Wounds closed faster with TBG than without it (15.3 vs. 16.5 days; mean intra-individual difference=-1.1 days [95% CI, 1.5 to 0.7]; p<0.0001). This agreed with unblinded direct clinical assessment (difference=-2.1 days [95% CI, -2.7 to -1.5]; p<0.0001). Adverse events possibly related to treatment were mild or moderate and mostly at the application site. TBG accelerates re-epithelialization of partial thickness wounds compared to the current standard of care, providing a well-tolerated contribution to burn care in practice. (C) 2017 The Authors. Published by Elsevier Ltd.